SCHEMBL25050591

SCHEMBL25050591

c1ccc(-c2cccc3ccccc23)c(-c2cc(-c3cccc4c3oc3ccccc34)nc(-c3ccc4c5ccccc5c5ccccc5c4c3)n2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.45
ALDH1A1 P00352 5/20 0.37
HSD17B10 Q99714 5/20 0.37
MAPT P10636 5/20 0.37
KDM4E B2RXH2 4/20 0.37
HPGD P15428 4/20 0.37
GAA P10253 1/20 0.37
PRKDC P78527 4/20 0.37
PIK3CD O00329 1/20 0.35
PIK3CB P42338 1/20 0.35
ATM Q13315 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
RAB9A P51151 1/20 0.35
GGPS1 O95749 1/20 0.35
PIM1 P11309 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
ENPP3 O14638 1/20 0.34
ENPP1 P22413 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25050542 0.94 ALOX5 (0.46) ALOX5ALDH1A1HSD17B10MAPTKDM4E
SCHEMBL25050589 0.94 ALOX5 (0.46) ALOX5ALDH1A1HSD17B10MAPTKDM4E
SCHEMBL25049892 0.89 ALOX5 (0.46) ALOX5ALDH1A1HSD17B10MAPTKDM4E
SCHEMBL25050238 0.88 ALOX5 (0.45) ALOX5ALDH1A1HSD17B10MAPTKDM4E
SCHEMBL25050601 0.87 ALOX5 (0.40) ALOX5ALDH1A1HSD17B10MAPTKDM4E
SCHEMBL25050541 0.87 ALOX5 (0.40) ALOX5ALDH1A1HSD17B10MAPTKDM4E
SCHEMBL25050026 0.85 ALOX5 (0.41) ALOX5ALDH1A1HSD17B10MAPTKDM4E
SCHEMBL25049890 0.85 ALOX5 (0.42) ALOX5ALDH1A1HSD17B10MAPTKDM4E
SCHEMBL22084486 0.85 ALOX5 (0.43) ALOX5ALDH1A1HSD17B10MAPTKDM4E
SCHEMBL22889281 0.83 ALOX5 (0.45) ALOX5ALDH1A1HSD17B10MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230047894-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO.,LTD. (JP) 2023-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230047894-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME AOC2, OR10J3, AOC3 ALOX5 3242/4885ALDH1A1 491/4885HSD17B10 2902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.